![Jürgen E. Bader](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jürgen E. Bader
Plus aucun poste en cours
Profil
Jürgen E.
Bader worked as the Head of Pharmaceutical Production at ESBATech AG.
Anciens postes connus de Jürgen E. Bader
Sociétés | Poste | Fin |
---|---|---|
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Corporate Officer/Principal | 01/05/2017 |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
ESBATech, a Novartis Co. GmbH
![]() ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Commercial Services |